Publications lacking in-depth information and analysis of essential aspects of GLP-1-RAs, such as mechanisms of action, clinical effectiveness, safety profiles, relevance to T2DM treatment, and weight control, were omitted. The gene discussed is GLP1R; the disease is type 2 diabetes mellitus.